Restaging Patients with Rectal Cancer Following Neoadjuvant Chemoradiation: A Systematic Review
ConclusionsAlthough restaging between completion of neoadjuvant chemo/XRT and proctectomy detects disease progression in only a small percentage of patients, findings alter the treatment plan in the vast majority of these patients. Multi-institutional collaboration with analysis of well-defined prognostic variables may better identify patients most likely to benefit from restaging.
Source: World Journal of Surgery - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Liver | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Science | Study | Surgery | Urology & Nephrology